▲ ⓒ Nature Cell[트리니티메디컬뉴스=박시정기자] The world’s first autologous adipose-derived mesenchymal stem cells are used to treat severe knee degenerative arthritis,’Jointstem’. 3For all patients in the phase clinical trial 6Month follow-up has been completed.. This clinical trial, which targets the largest number of stem cell clinical trials in Korea, has ended..
Nature Cell is a joint-stem domestic clinical trial agency, Gangdong Kyunghee University Hospital., Seoul National University Hospital, Severance Hospital, Samsung Medical Center, etc. 13Shot at dog university hospital 247Name KL 3Joint stem for patients with grade severe degenerative arthritis 3Phase clinical trial 6Month follow-up was completed. 29Sun said. Joint stem was developed by RBIO Co., Ltd., Nature Cell owns the domestic copyright.
All in this clinical trial 261Enrolled in, double 252Investigational drugs were administered to three patients,, Among them, 14Final excluding people 247About people
6Month follow-up has been completed.. This is the largest number of patients in clinical trials for stem cell therapy in Korea..
Joint stem 3Phase clinical trial ahead 2019year Onemonth 31Same year after approval from the Ministry of Food and Drug Safety 7In May, the first patient was administered clinical trial drugs at Gangdong Kyunghee University Hospital. From this about 11Over the months Nationwide 13Dog Clinical Trial Agency(University Hospital)in
252Investigational drugs were administered to three patients.. after, Follow-up of each patient proceeded smoothly,, Last 15Last day of the patient 6Month follow-up has been completed..
Accordingly, Albaio is a clinical trial consignment institution(CRO)And entered the clinical trial termination procedure. next year 1/4It is expected that results will be drawn during the quarter..
Dr. Jeong-Chan Ra, director of the Biostar Stem Cell Technology Research Institute, who is in charge of research and development at JointStem, said, “Corona19“I would like to thank the people involved in the clinical trial for progressing smoothly despite the difficulty in conducting the clinical trial because of this.”2021In 2012, we will make thorough preparations so that we can obtain an item license from JointStem.”Said.